Clinical Trial Results
Search
Dr. Kevin Alexander and Dr. C. Michael Gibson discuss: Acoramidis reduces cardiovascular mortality (CVM): results at month 42 from the ATTRibute-CM open-label extension (OLE) study
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.
Dr. Alberto Morales and Dr. C Michael Gibson discuss: Non-Invasive Atherosclerosis Evaluation: What Can We See and What are We Looking For?
Sponsored by: Cleerly, Women as One, and International Atherosclerosis Society
Dr. Daniel Chamie and Dr. C. Michael Gibson discuss: Clinical Utility of Atherosclerosis Imaging: Lessons Learned from Intravascular Ultrasound
Sponsored by Cleerly, Women as One, and International Atherosclerosis Society
Dr. Nick Nurmohamed and Dr. C. Michael Gibson discuss: What We Thought Was Wrong: Evolution of the Approach to Evaluation and Treatment of Coronary Artery Disease
Disclosures: Sponsored by Cleerly, Women as One, and International Atherosclerosis Society
Dr. Fatima Rodriguez and Dr. C. Michael Gibson discuss: Atherosclerosis: Basic Concepts and Current Understanding
Sponsored by: Cleerly, Women as One and International Atherosclerosis Society